메뉴 건너뛰기




Volumn 53, Issue 3, 2012, Pages 529-538

Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique

Author keywords

Absorption fraction; Carbamazepine derivatives; Intestinal permeability; Mouse small intestine; P glycoprotein; Ussing chamber

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; GLYCOPROTEIN P INHIBITOR; LICARBAZEPINE; OXCARBAZEPINE; VERAPAMIL;

EID: 84857546604     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03409.x     Document Type: Article
Times cited : (51)

References (63)
  • 4
    • 0033812631 scopus 로고    scopus 로고
    • In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil
    • Annaert P, Tukker J, Gelder J, Naesens L, Clercq E, Mooter G, Kinget R, Augustijns P,. (2000) In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil. J Pharm Sci 89: 1054-1062.
    • (2000) J Pharm Sci , vol.89 , pp. 1054-1062
    • Annaert, P.1    Tukker, J.2    Gelder, J.3    Naesens, L.4    Clercq, E.5    Mooter, G.6    Kinget, R.7    Augustijns, P.8
  • 5
    • 0347033287 scopus 로고    scopus 로고
    • Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors
    • DOI 10.1016/S0306-4522(02)00992-2
    • Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Leenstra S, Ramkema M, Scheffer GL, Scheper RJ, Troost D,. (2003) Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118: 417-429. (Pubitemid 36423257)
    • (2003) Neuroscience , vol.118 , Issue.2 , pp. 417-429
    • Aronica, E.1    Gorter, J.A.2    Jansen, G.H.3    Van Veelen, C.W.M.4    Van Rijen, P.C.5    Leenstra, S.6    Ramkema, M.7    Scheffer, G.L.8    Scheper, R.J.9    Troost, D.10
  • 7
    • 33846271368 scopus 로고    scopus 로고
    • Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein
    • DOI 10.1016/j.neuropharm.2006.07.038, PII S002839080600270X
    • Baltes S, Gastens A, Fedrowitz M, Potschka H, Kaever V, Löscher W,. (2007) Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52: 333-346. (Pubitemid 46123353)
    • (2007) Neuropharmacology , vol.52 , Issue.2 , pp. 333-346
    • Baltes, S.1    Gastens, A.M.2    Fedrowitz, M.3    Potschka, H.4    Kaever, V.5    Loscher, W.6
  • 8
    • 74049163222 scopus 로고    scopus 로고
    • Key factors in the discovery and development of new antiepileptic drugs
    • Bialer M, White H,. (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9: 68-82.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 68-82
    • Bialer, M.1    White, H.2
  • 9
    • 0000312699 scopus 로고    scopus 로고
    • Physicochemical and drug-delivery considerations for oral drug bioavailability
    • DOI 10.1016/1359-6446(96)10039-8
    • Chan O, Stewart B,. (1996) Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discov Today 1: 461-473. (Pubitemid 126393548)
    • (1996) Drug Discovery Today , vol.1 , Issue.11 , pp. 461-473
    • Chan, O.H.1    Stewart, B.H.2
  • 10
    • 44749090398 scopus 로고    scopus 로고
    • A novel design of artificial membrane for improving the PAMPA model
    • Chen X, Murawski A, Patel K, Crespi C, Balimane P,. (2008) A novel design of artificial membrane for improving the PAMPA model. Pharm Res 25: 1511-1520.
    • (2008) Pharm Res , vol.25 , pp. 1511-1520
    • Chen, X.1    Murawski, A.2    Patel, K.3    Crespi, C.4    Balimane, P.5
  • 11
    • 67049146675 scopus 로고    scopus 로고
    • A guide to Ussing chamber studies of mouse intestine
    • Clarke L,. (2009) A guide to Ussing chamber studies of mouse intestine. Am J Physiol Gastrointest Liver Physiol 296: G1151-G1166.
    • (2009) Am J Physiol Gastrointest Liver Physiol , vol.296
    • Clarke, L.1
  • 12
    • 58149164868 scopus 로고    scopus 로고
    • In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption
    • del Amo E, Heikkinen A, Mönkkönen J,. (2009) In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. Eur J Pharm Sci 36: 200-211.
    • (2009) Eur J Pharm Sci , vol.36 , pp. 200-211
    • Del Amo, E.1    Heikkinen, A.2    Mönkkönen, J.3
  • 13
    • 40049110714 scopus 로고    scopus 로고
    • Carrier-mediated cellular uptake of pharmaceutical drugs: An exception or the rule?
    • DOI 10.1038/nrd2438, PII NRD2438
    • Dobson P, Kell D,. (2008) Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7: 205-220. (Pubitemid 351321232)
    • (2008) Nature Reviews Drug Discovery , vol.7 , Issue.3 , pp. 205-220
    • Dobson, P.D.1    Kell, D.B.2
  • 14
    • 0036093847 scopus 로고    scopus 로고
    • The mucosa of the small intestine: How clinically relevant as an organ of drug metabolism?
    • Doherty M, Charman W,. (2002) The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin Pharmacokinet 41: 235-253. (Pubitemid 34533755)
    • (2002) Clinical Pharmacokinetics , vol.41 , Issue.4 , pp. 235-253
    • Doherty, M.M.1    Charman, W.N.2
  • 15
    • 77953806616 scopus 로고    scopus 로고
    • Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma
    • Fortuna A, Sousa J, Alves G, Falcão A, Soares-da-Silva P,. (2010) Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma. Anal Bioanal Chem 397: 1605-1615.
    • (2010) Anal Bioanal Chem , vol.397 , pp. 1605-1615
    • Fortuna, A.1    Sousa, J.2    Alves, G.3    Falcão, A.4    Soares-Da-Silva, P.5
  • 16
    • 84857558058 scopus 로고    scopus 로고
    • In vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: Focus on rhodamine 123, digoxin, and talinolol
    • Fortuna A, Alves G, Falcão A,. (2011) In vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: focus on rhodamine 123, digoxin, and talinolol. J Bioequiv Availab S2: 001-023.
    • (2011) J Bioequiv Availab , vol.2 S , pp. 001-023
    • Fortuna, A.1    Alves, G.2    Falcão, A.3
  • 18
    • 0035005884 scopus 로고    scopus 로고
    • Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine
    • DOI 10.1016/S0920-1211(01)00231-5, PII S0920121101002315
    • Hainzl D, Parada A, Soares-da-Silva P,. (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 44: 197-206. (Pubitemid 32452229)
    • (2001) Epilepsy Research , vol.44 , Issue.2-3 , pp. 197-206
    • Hainzl, D.1    Parada, A.2    Soares-Da-Silva, P.3
  • 20
    • 24344439264 scopus 로고    scopus 로고
    • Transporters and drug therapy: Implications for drug disposition and disease
    • DOI 10.1016/j.clpt.2005.05.011, PII S0009923605002250
    • Ho R, Kim R,. (2005) Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 78: 260-277. (Pubitemid 41254111)
    • (2005) Clinical Pharmacology and Therapeutics , vol.78 , Issue.3 , pp. 260-277
    • Ho, R.H.1    Kim, R.B.2
  • 22
    • 77649216536 scopus 로고    scopus 로고
    • Membrane transporters in drug development
    • International Transporter Consortium.
    • International Transporter Consortium. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9: 215-236.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 215-236
  • 24
    • 51249095402 scopus 로고    scopus 로고
    • Use of the biopharmaceutical classification system in early drug development
    • Ku M,. (2008) Use of the biopharmaceutical classification system in early drug development. AAPS J 10: 208-212.
    • (2008) AAPS J , vol.10 , pp. 208-212
    • Ku, M.1
  • 25
    • 1442302325 scopus 로고    scopus 로고
    • Intestinal drug transporters: In vivo function and clinical importance
    • DOI 10.2174/1389200043489144
    • Kunta J, Sinko P,. (2004) Intestinal drug transporters: in vivo function and clinical importance. Curr Drug Metab 5: 109-124. (Pubitemid 38292004)
    • (2004) Current Drug Metabolism , vol.5 , Issue.1 , pp. 109-124
    • Kunta, J.R.1    Sinko, P.J.2
  • 26
    • 77954625557 scopus 로고    scopus 로고
    • Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
    • Kwan P, Arzimanoglou A, Berg A, Brodie M, Hauser W, Mathern G, Moshé S, Perucca E, Wiebe S, French J,. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069-1077.
    • (2010) Epilepsia , vol.51 , pp. 1069-1077
    • Kwan, P.1    Arzimanoglou, A.2    Berg, A.3    Brodie, M.4    Hauser, W.5    Mathern, G.6    Moshé, S.7    Perucca, E.8    Wiebe, S.9    French, J.10
  • 27
    • 35349012642 scopus 로고    scopus 로고
    • Animal data: The contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo
    • DOI 10.1016/j.addr.2007.06.016, PII S0169409X07001706, Prediction of Therapeutic and Drug Delivery Outcomes Using Animal Models
    • Lennernäs H,. (2007) Animal data: the contributions of the Ussing chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev 59: 1103-1120. (Pubitemid 47615203)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.11 , pp. 1103-1120
    • Lennernas, H.1
  • 28
    • 38149073214 scopus 로고    scopus 로고
    • A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs
    • Linnet K, Ejsing T,. (2008) A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsycopharmacol 18: 157-169.
    • (2008) Eur Neuropsycopharmacol , vol.18 , pp. 157-169
    • Linnet, K.1    Ejsing, T.2
  • 29
    • 67650215631 scopus 로고    scopus 로고
    • Third-generation antiepileptic drugs: Mechanisms of action, pharmacokinetics and interactions
    • Luszczki J,. (2009) Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep 61: 197-216.
    • (2009) Pharmacol Rep , vol.61 , pp. 197-216
    • Luszczki, J.1
  • 30
    • 77950479087 scopus 로고    scopus 로고
    • The anticonvulsants market
    • Mackey C,. (2010) The anticonvulsants market. Nat Rev Drug Discov 9: 265-266.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 265-266
    • MacKey, C.1
  • 31
    • 27244446035 scopus 로고    scopus 로고
    • A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy- 5H- dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine
    • DOI 10.1111/j.1528-1167.2005.00265.x
    • Marchi N, Guiso G, Rizzi M, Pirker S, Novak K, Czech T, Baumgartner C, Janigro D, Caccia S, Vezzani A,. (2005) A pilot study on brain-to-plasma partition of 10,11-Dyhydro-10- hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. Epilepsia 46: 1613-1620. (Pubitemid 44921935)
    • (2005) Epilepsia , vol.46 , Issue.10 , pp. 1613-1620
    • Marchi, N.1    Guiso, G.2    Rizzi, M.3    Pirker, S.4    Novak, K.5    Czech, T.6    Baumgartner, C.7    Janigro, D.8    Caccia, S.9    Vezzani, A.10
  • 35
    • 78349255907 scopus 로고    scopus 로고
    • Temporal trends in the mortality of people with epilepsy: A review
    • Neligan A, Bell G, Shorvon S, Sander J,. (2010) Temporal trends in the mortality of people with epilepsy: a review. Epilepsia 51: 2241-2246.
    • (2010) Epilepsia , vol.51 , pp. 2241-2246
    • Neligan, A.1    Bell, G.2    Shorvon, S.3    Sander, J.4
  • 36
  • 37
    • 77951034037 scopus 로고    scopus 로고
    • Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin
    • Pathak S, Udupa N,. (2010) Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin. Biopharm Drug Dispos 31: 202-214.
    • (2010) Biopharm Drug Dispos , vol.31 , pp. 202-214
    • Pathak, S.1    Udupa, N.2
  • 38
    • 34547828792 scopus 로고    scopus 로고
    • Development of new antiepileptic drugs: Challenges, incentives, and recent advances
    • DOI 10.1016/S1474-4422(07)70215-6, PII S1474442207702156
    • Perucca E, French J, Bialer M,. (2007) Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol 6: 793-804. (Pubitemid 47243712)
    • (2007) Lancet Neurology , vol.6 , Issue.9 , pp. 793-804
    • Perucca, E.1    French, J.2    Bialer, M.3
  • 39
    • 72049119592 scopus 로고    scopus 로고
    • Targeting regulation of ABC efflux transporters in brain diseases: A novel therapeutic approach
    • Potschka H,. (2010) Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach. Pharmacol Ther 125: 118-127.
    • (2010) Pharmacol Ther , vol.125 , pp. 118-127
    • Potschka, H.1
  • 40
    • 0142148142 scopus 로고    scopus 로고
    • Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques
    • DOI 10.1124/jpet.103.053504
    • Raje S, Cao J, Newman A, Gao H, Eddington N,. (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307: 801-808. (Pubitemid 37310698)
    • (2003) Journal of Pharmacology and Experimental Therapeutics , vol.307 , Issue.2 , pp. 801-808
    • Raje, S.1    Cao, J.2    Newman, A.H.3    Gao, H.4    Eddington, N.D.5
  • 41
    • 33747049831 scopus 로고    scopus 로고
    • Diverse mechanisms of antiepileptic drugs in the development pipeline
    • DOI 10.1016/j.eplepsyres.2006.02.004, PII S0920121106000635
    • Rogawski M,. (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69: 273-294. (Pubitemid 44209049)
    • (2006) Epilepsy Research , vol.69 , Issue.3 , pp. 273-294
    • Rogawski, M.A.1
  • 43
    • 77956631702 scopus 로고    scopus 로고
    • Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery
    • Sajeesh S, Vauthier C, Gueutin C, Ponchel G, Sharma C,. (2010) Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. Acta Biomater 6: 3072-3080.
    • (2010) Acta Biomater , vol.6 , pp. 3072-3080
    • Sajeesh, S.1    Vauthier, C.2    Gueutin, C.3    Ponchel, G.4    Sharma, C.5
  • 44
    • 79953724893 scopus 로고    scopus 로고
    • Efficacy of new antiepileptic drugs
    • Schmidt D,. (2011a) Efficacy of new antiepileptic drugs. Epilepsy Curr 11: 9-11.
    • (2011) Epilepsy Curr , vol.11 , pp. 9-11
    • Schmidt, D.1
  • 45
    • 79961212342 scopus 로고    scopus 로고
    • Antiepileptic drug discovery: Does mechanism of action matter?
    • Schmidt D,. (2011b) Antiepileptic drug discovery: does mechanism of action matter? Epilepsy Behav 21: 342-343.
    • (2011) Epilepsy Behav , vol.21 , pp. 342-343
    • Schmidt, D.1
  • 46
    • 20544475805 scopus 로고    scopus 로고
    • Drug resistance in epilepsy: Putative neurobiologic and clinical mechanisms
    • DOI 10.1111/j.1528-1167.2005.54904.x
    • Schmidt D, Löscher W,. (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46: 858-877. (Pubitemid 40847354)
    • (2005) Epilepsia , vol.46 , Issue.6 , pp. 858-877
    • Schmidt, D.1    Loscher, W.2
  • 47
    • 84455196058 scopus 로고    scopus 로고
    • The controversy over generic antiepileptic drugs
    • Shaw S, Hartman A,. (2010) The controversy over generic antiepileptic drugs. J Pediatr Pharmacol Ther 15: 81-93.
    • (2010) J Pediatr Pharmacol Ther , vol.15 , pp. 81-93
    • Shaw, S.1    Hartman, A.2
  • 48
    • 68149170038 scopus 로고    scopus 로고
    • The role of transporters in pharmacokinetics of orally administered drugs
    • Shugarts S, Benet L,. (2009) The role of transporters in pharmacokinetics of orally administered drugs. Pharm Res 26: 2039-2054.
    • (2009) Pharm Res , vol.26 , pp. 2039-2054
    • Shugarts, S.1    Benet, L.2
  • 49
    • 77953303004 scopus 로고    scopus 로고
    • Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay
    • Skolnik S, Lin X, Wang J, Chen X, He T, Zhang B,. (2010) Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay. J Pharm Sci. 99: 3246-3265.
    • (2010) J Pharm Sci , vol.99 , pp. 3246-3265
    • Skolnik, S.1    Lin, X.2    Wang, J.3    Chen, X.4    He, T.5    Zhang, B.6
  • 50
    • 79953682225 scopus 로고    scopus 로고
    • Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma
    • Sousa J, Alves G, Fortuna A, Pena A, Lino C, Falcão A,. (2011) Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma. Biomed Chromatogr 25: 535-541.
    • (2011) Biomed Chromatogr , vol.25 , pp. 535-541
    • Sousa, J.1    Alves, G.2    Fortuna, A.3    Pena, A.4    Lino, C.5    Falcão, A.6
  • 51
    • 0036246888 scopus 로고    scopus 로고
    • Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice
    • Stephens R, O'Neil C, Bennett J, Humphrey M, Henry B, Rowland M, Warhurst G,. (2002) Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (7/7) mice. Br J Pharmacol 135: 2038-2046. (Pubitemid 34478317)
    • (2002) British Journal of Pharmacology , vol.135 , Issue.8 , pp. 2038-2046
    • Stephens, R.H.1    O'Neill, C.A.2    Bennett, J.3    Humphrey, M.4    Henry, B.5    Rowland, M.6    Warhurst, G.7
  • 52
    • 0035977897 scopus 로고    scopus 로고
    • The importance of drug-transporting P-glycoproteins in toxicology
    • DOI 10.1016/S0378-4274(01)00304-6, PII S0378427401003046
    • Tellingen O,. (2001) The importance of drug transporting P-glycoproteins in toxicology. Toxicol Lett 120: 31-41. (Pubitemid 32375068)
    • (2001) Toxicology Letters , vol.120 , Issue.1-3 , pp. 31-41
    • Van Tellingen, O.1
  • 53
    • 67650591025 scopus 로고    scopus 로고
    • New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments
    • Tran H, Tran P, Lee B,. (2009) New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments. Int J Pharm 378: 9-16.
    • (2009) Int J Pharm , vol.378 , pp. 9-16
    • Tran, H.1    Tran, P.2    Lee, B.3
  • 54
    • 0033862088 scopus 로고    scopus 로고
    • Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines
    • DOI 10.1016/S0928-0987(00)00097-X, PII S092809870000097X
    • van der Sandt I, Blom-Roosemalen M, de Boer A, Breimer D,. (2000) Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 11: 207-214. (Pubitemid 30616443)
    • (2000) European Journal of Pharmaceutical Sciences , vol.11 , Issue.3 , pp. 207-214
    • Van Der Sandt, I.1    Blom-Roosemalen, M.2    De Boer, A.3    Breimer, D.4
  • 55
    • 0035953319 scopus 로고    scopus 로고
    • Property-based design: Optimization of drug absorption and pharmacokinetics
    • DOI 10.1021/jm000407e
    • van De Waterbeemd H, Smith D, Beaumont K, Walker D,. (2001) Property-based design: optimization of drug absorption and pharmacokinetics. J Med Chem 44: 1313-1333. (Pubitemid 32852106)
    • (2001) Journal of Medicinal Chemistry , vol.44 , Issue.9 , pp. 1313-1333
    • Van De Waterbeemd, H.1    Smith, D.2    Beaumont, K.3    Walker, D.4
  • 56
    • 20744447950 scopus 로고    scopus 로고
    • Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo
    • DOI 10.1016/j.ejps.2005.04.003, PII S0928098705001247
    • Varma M, Panchagnula R,. (2005) Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 25: 445-453. (Pubitemid 40853872)
    • (2005) European Journal of Pharmaceutical Sciences , vol.25 , Issue.4-5 , pp. 445-453
    • Varma, M.V.S.1    Panchagnula, R.2
  • 57
    • 78649674647 scopus 로고    scopus 로고
    • Application of method suitability for drug permeability classification
    • Volpe D,. (2010) Application of method suitability for drug permeability classification. AAPS J 12: 670-678.
    • (2010) AAPS J , vol.12 , pp. 670-678
    • Volpe, D.1
  • 58
    • 0029836840 scopus 로고    scopus 로고
    • HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: In vitro-in vivo correlation with permeability data from rats and humans
    • DOI 10.1021/js960110x
    • Walter E, Janich S, Roessler B, Hilfinger J, Amidon G,. (1996) HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 85: 1070-1076. (Pubitemid 26338920)
    • (1996) Journal of Pharmaceutical Sciences , vol.85 , Issue.10 , pp. 1070-1076
    • Walter, E.1    Janich, S.2    Roessler, B.J.3    Hilfinger, J.M.4    Amidon, G.L.5
  • 59
    • 4644327060 scopus 로고    scopus 로고
    • A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method
    • DOI 10.1016/j.ejpb.2004.03.029, PII S0939641104001109
    • Watanabe E, Takahashi M, Hayashi M,. (2004) A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method. Eur J Pharm Biopharm 58: 659-665. (Pubitemid 39297114)
    • (2004) European Journal of Pharmaceutics and Biopharmaceutics , vol.58 , Issue.3 , pp. 659-665
    • Watanabe, E.1    Takahashi, M.2    Hayashi, M.3
  • 61
    • 33344454616 scopus 로고    scopus 로고
    • Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine
    • DOI 10.1016/j.jconrel.2005.11.011, PII S0168365905006541
    • Werle M, Hoffer M,. (2006) Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111: 41-46. (Pubitemid 43289993)
    • (2006) Journal of Controlled Release , vol.111 , Issue.1-2 , pp. 41-46
    • Werle, M.1    Hoffer, M.2
  • 62
    • 33645314628 scopus 로고    scopus 로고
    • Ciprofloxacin permeability and its active secretion through rat small intestine in vitro
    • Zakelj S, Sturm K, Kristl A,. (2006) Ciprofloxacin permeability and its active secretion through rat small intestine in vitro. Int J Pharm 313: 175-180.
    • (2006) Int J Pharm , vol.313 , pp. 175-180
    • Zakelj, S.1    Sturm, K.2    Kristl, A.3
  • 63
    • 79958829984 scopus 로고    scopus 로고
    • Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: Implications for predicting in vivo drug interactions
    • Zolnerciks J, Booth-Genthe C, Gupta A, Harris J, Unadkat J,. (2011) Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions. J Pharm Sci 100: 3055-3061.
    • (2011) J Pharm Sci , vol.100 , pp. 3055-3061
    • Zolnerciks, J.1    Booth-Genthe, C.2    Gupta, A.3    Harris, J.4    Unadkat, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.